ADAR1 Capital Management »

Pyxis Oncology shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Pyxis Oncology (PYXS) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Pyxis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Pyxis Oncology held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pyxis Oncology by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $37k 10k 3.67
2024-06-30 $33k 10k 3.31
2024-03-31 $43k 10k 4.26

More positions owned by ADAR1 Capital Management

Cytokinetics Com New (CYTK)
Protagonist Therapeutics (PTGX)
Bridgebio Pharma (BBIO)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Zura Bio Class A Ord Shs (ZURA)
Zai Lab Adr (ZLAB)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Aa Mission Acquisition Corp Ord Shs Cl A (AAM)
Mineralys Therapeutics (MLYS)
Syndax Pharmaceuticals (SNDX)

View all positions for ADAR1 Capital Management

Top funds holding Pyxis Oncology

Deep Track Capital
Laurion Capital Management
BlackRock
Vanguard Group
Millennium Management
Ikarian Capital
Blue Owl Capital Holdings
Geode Capital Management
State Street Corporation
Standard Life Aberdeen
Stempoint Capital
Perceptive Advisors
683 Capital Management
Northern Trust
Jacobs Levy Equity Management

View all funds holding Pyxis Oncology